Article Information
History
- October 12, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hélène Bricout1,*,
- Marie-Cécile Levant1,
- Pascal Crépey2,
- Gaëtan Gavazzi3,4,
- Jacques Gaillat5,
- Marie Dufournet6,
- Nada Assi7,
- Benjamin Grenier8,
- Fanny Raguideau8,
- Fabienne Péretz9,
- Camille Salamand6,
- Anne Mosnier10,
- Laurence Watier11,
- Odile Launay12 and
- Matthew M. Loiaconol13
- 1Medical Department, Sanofi Vaccines, Lyon, France
- 2Ecole des hautes études en santé publique, CNRS, Université de Rennes, ARENES - UMR 6051, Recherche sur les services et le management en santé – Inserm U 1309, Rennes, France
- 3CHU Grenoble Alpes, Service Universitaire de Gériatrie Clinique, CS 10217, Grenoble, France
- 4Laboratoire T-Raig TIMC-IMAG CNRS 5525 Université Grenoble-Alpes, France
- 5Service de Maladies Infectieuses, Centre Hospitalier Annecy Genevois, Annecy, France
- 6Biostatistics Department, Sanofi Vaccines, Lyon, France
- 7HEVA, Pôle Statistiques, Lyon, France
- 8HEVA, Pôle Epidémiologie, Lyon, France
- 9Abelia Science, Saint-Georges-sur-Baulche, France
- 10Open Rome, Paris, France
- 11Epidemiology and modeling of bacterial escape to antimicrobials, Institut Pasteur, Paris, France
- 12Université Paris Cité; Inserm CIC 1417; Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Université Cité Paris, Paris, France
- 13Medical Evidence Generation, Sanofi Vaccines, Swiftwater, PA, USA
- ↵*Corresponding author: Hélène Bricout, Sanofi Vaccines, 14 Espace Henry Vallée, 69007 Lyon, France. Tel: +33 (0)6 33 31 08 99; E-mail: helene.bricout{at}sanofi.com
Posted October 12, 2024.
Relative effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalizations: a national retrospective cohort study in France, 2022/23 season
